Paper35596242
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management.
Fehily SR and 11 others. Aliment Pharmacol Ther, 2022. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management. Papers, record 35596242. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35596242
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Inflammatory Bowel Diseases | Major topic |
| Latent Tuberculosis | Major topic |
| Humans | |
| Immunosuppression Therapy | |
| Interferon-gamma Release Tests | |
| Mass Screening | |
| Tuberculin Test | |
| Tumor Necrosis Factor-alpha |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 36641788 | Letter: Ozanimod and latent tuberculosis. | https://conductscience.org/library/papers/36641788 |
Source PubMed
References163
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10764341 | Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. | Am J Respir Crit Care Med | 2000 | https://conductscience.org/library/papers/10764341 | PubMed |
| 2 | 17021358 | An official ATS statement: hepatotoxicity of antituberculosis therapy. | Am J Respir Crit Care Med | 2006 | https://conductscience.org/library/papers/17021358 | PubMed |
| 3 | 32387584 | Early discontinuation of tofacitinib in patients with rheumatoid arthritis co-treated with rifampin for latent tuberculosis. | Joint Bone Spine | 2020 | https://conductscience.org/library/papers/32387584 | PubMed |
| 4 | 15610671 | Health Risks Associated with Visiting Friends and Relatives in Developing Countries. | Curr Infect Dis Rep | 2005 | https://conductscience.org/library/papers/15610671 | PubMed |
| 5 | 27484275 | British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016. | Br J Dermatol | 2016 | https://conductscience.org/library/papers/27484275 | PubMed |
| 6 | 29757355 | A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-mediated Inflammatory Diseases. | J Crohns Colitis | 2018 | https://conductscience.org/library/papers/29757355 | PubMed |
| 7 | 25130049 | Evidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous dermatoses. | Br J Dermatol | 2014 | https://conductscience.org/library/papers/25130049 | PubMed |
| 8 | 27192092 | Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/27192092 | PubMed |
| 9 | 22062358 | Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. | Gastroenterology | 2012 | https://conductscience.org/library/papers/22062358 | PubMed |
| 10 | 20393175 | Infliximab, azathioprine, or combination therapy for Crohn's disease. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20393175 | PubMed |
| 11 | 10228190 | Infliximab for the treatment of fistulas in patients with Crohn's disease. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10228190 | PubMed |
| 12 | 24454900 | Tuberculosis contact investigation using interferon-gamma release assay with chest x-ray and computed tomography. | PLoS One | 2014 | https://conductscience.org/library/papers/24454900 | PubMed |
| 13 | 27683798 | Long-term Efficacy of Vedolizumab for Crohn's Disease. | J Crohns Colitis | 2017 | https://conductscience.org/library/papers/27683798 | PubMed |
| 14 | 22803615 | The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection. | Br J Dermatol | 2012 | https://conductscience.org/library/papers/22803615 | PubMed |
| 15 | 16678077 | Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. | Clin Gastroenterol Hepatol | 2006 | https://conductscience.org/library/papers/16678077 | PubMed |
| 16 | 27780211 | The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. | PLoS Med | 2016 | https://conductscience.org/library/papers/27780211 | PubMed |
| 17 | 21180608 | Optimizing therapy with 6-mercaptopurine and azathioprine: to measure or not to measure? | Ther Adv Gastroenterol | 2010 | https://conductscience.org/library/papers/21180608 | PubMed |
| 18 | 31656117 | High risk of activation of latent tuberculosis infection in rheumatic disease patients. | Infect Dis (Lond) | 2020 | https://conductscience.org/library/papers/31656117 | PubMed |
| 19 | 18564448 | Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases for candidates for therapy with tumor necrosis factor alpha inhibitors--March 2008 update. | Rev Port Pneumol | 2008 | https://conductscience.org/library/papers/18564448 | PubMed |
| 20 | 30373275 | Trends of Medication Usage and Associated Outcomes for Taiwanese Patients with Inflammatory Bowel Disease from 2001 to 2015. | J Clin Med | 2018 | https://conductscience.org/library/papers/30373275 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42704580 | IBD Nurse-Led Clinical Pathways to Optimize Patient Safety in Advanced Therapies: A Narrative Review. | Dig Dis Sci | 2026 | https://conductscience.org/library/papers/42704580 | PubMed |
| 42351542 | Detection of Latent Tuberculosis Infection in Patients with Rheumatological Diseases Who Receive Immunosuppressive Therapy. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42351542 | PubMed |
| 42291945 | Biologic Therapy in Ulcerative Colitis: A Retrospective Real-World Study in a Brazilian Tertiary University Hospital. | Cureus | 2026 | https://conductscience.org/library/papers/42291945 | PubMed |
| 42125169 | Coexisting Hepatic and Renal Dysfunction During Pulmonary Tuberculosis Treatment: A Case Report. | Clin Case Rep | 2026 | https://conductscience.org/library/papers/42125169 | PubMed |
| 42039264 | Targeted intestinal barrier repair via probiotic-derived engineered outer membrane vesicles: A 3A1M strategy with antioxidant, anti-inflammatory, anti-ferroptotic, and microbiome modulation effects. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42039264 | PubMed |
| 41803488 | Prevalence and clinical impact of latent tuberculosis infection in patients with inflammatory bowel disease in Japan: a retrospective multicenter study by the IBD-Quality team. | J Gastroenterol | 2026 | https://conductscience.org/library/papers/41803488 | PubMed |
| 41446278 | CD14- CD16+ monocyte PD-L1 prevents early tuberculosis progression and constrains reactivation under immune checkpoint therapy. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41446278 | PubMed |
| 41399929 | Dormant yet dangerous: the role of cell rest in perseverance. | Future Microbiol | 2025 | https://conductscience.org/library/papers/41399929 | PubMed |
| 40980788 | A Fatal Case of Anti-PL-7 Antibody-Associated Rapidly Progressive Interstitial Lung Disease Complicated by Tuberculosis: A Case Report. | Cureus | 2025 | https://conductscience.org/library/papers/40980788 | PubMed |
| 40764876 | Assessing tuberculosis risk in Crohn's disease patients receiving biologic therapies: real-world insights from Japan. | Intest Res | 2025 | https://conductscience.org/library/papers/40764876 | PubMed |
| 40725683 | Prevalence and Risk Factors of Latent Tuberculosis Infection Detected by IGRA in Patients with Immune-Mediated Inflammatory Diseases Before and During Biologic DMARD Therapy (TITAN Study). | J Clin Med | 2025 | https://conductscience.org/library/papers/40725683 | PubMed |
| 40580415 | Role of fecal calprotectin to differentiate between treatment-naive intestinal tuberculosis and Crohn's disease: A pilot study. | Indian J Gastroenterol | 2026 | https://conductscience.org/library/papers/40580415 | PubMed |
| 40430808 | Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report. | Pathogens | 2025 | https://conductscience.org/library/papers/40430808 | PubMed |
| 40421289 | Efficacy and safety of dual-targeted therapy for refractory inflammatory bowel disease: a retrospective case series from three tertiary general hospitals in China. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40421289 | PubMed |
| 40236937 | Persistent Abdominal Pain and Diarrhea After Appendectomy-Crohn's Disease Versus Intestinal Tuberculosis. | JGH Open | 2025 | https://conductscience.org/library/papers/40236937 | PubMed |
| 40197143 | Age-specific relationship between HIV and TB treatment outcomes in the West Region of Cameroon: a cross-sectional study. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/40197143 | PubMed |
| 40059900 | Biologics in the management of pediatric inflammatory bowel disease: When and what to choose. | World J Clin Pediatr | 2025 | https://conductscience.org/library/papers/40059900 | PubMed |
| 40046059 | Association of systemic inflammation response index with latent tuberculosis infection and all-cause mortality: a cohort study from NHANES 2011-2012. | Front Immunol | 2025 | https://conductscience.org/library/papers/40046059 | PubMed |
| 39987456 | Uncovering the therapeutic potential of anti-tuberculoid agent Isoniazid in a model of microbial-driven Crohn's disease. | J Crohns Colitis | 2025 | https://conductscience.org/library/papers/39987456 | PubMed |
| 39257584 | HBHA induces IL-10 from CD4+ T cells in patients with active tuberculosis but IFN-γ and IL-17 from individuals with Mycobacterium tuberculosis infection. | Front Immunol | 2024 | https://conductscience.org/library/papers/39257584 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| HPD | 3242 | PubTator's text mining | https://conductscience.org/library/genes/3242 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL12B | 3593 | PubTator's text mining | https://conductscience.org/library/genes/3593 | NCBI Gene |
| IL23A | 51561 | PubTator's text mining | https://conductscience.org/library/genes/51561 | NCBI Gene |
| IL9 | 3578 | PubTator's text mining | https://conductscience.org/library/genes/3578 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35596242
GET https://conductscience.org/api/papers/v1/35596242/references?page=2